# Chemomab Therapeutics Ltd.: Form SC 13D/A, filed Nov 15, 2023

- Company: [Chemomab Therapeutics Ltd.](/companies/cmmb.md) (CIK 1534248)
- Form: SC 13D/A
- Filed: 2023-11-15
- Accepted by EDGAR: Nov 15, 2023, 16:35 ET
- Period: not reported
- Accession: 0000947871-23-001083
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1534248/000094787123001083/ss2718111_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534248/000094787123001083/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534248/000094787123001083/ss2718111_sc13da.htm

Filed Nov 15, 2023.
Source: SEC EDGAR, the filing index for accession 0000947871-23-001083. Last ingested by Listed: Nov 2, 2026, 06:08 ET. No prices; not investment advice.